News
ZRSEF
36.22
NaN%
--
DocMorris Secures Oversubscribed CHF 96.8 Million Convertible Bond on Improved Terms
TipRanks · 09/11 18:02
DocMorris (DOCM) Receives a Buy from Deutsche Bank
TipRanks · 09/10 08:36
DocMorris Raises CHF 100 Million in Oversubscribed 2031 Convertible Bond to Refinance 2028 Notes
TipRanks · 09/09 16:05
DocMorris Refinances 2028 Convertible With New CHF 100 Million Issue
TipRanks · 09/09 05:32
DocMorris (DOCM) Receives a Hold from Jefferies
TipRanks · 09/03 13:05
DocMorris downgraded to Hold from Buy at Jefferies
TipRanks · 08/25 23:15
DocMorris price target raised to CHF 12.50 from CHF 11.50 at Deutsche Bank
TipRanks · 08/24 16:35
Deutsche Bank Sticks to Their Buy Rating for DocMorris (DOCM)
TipRanks · 08/24 07:25
DocMorris AG Earnings Call Signals AI‑Driven Turnaround
TipRanks · 08/22 00:08
Deutsche Bank Keeps Their Buy Rating on DocMorris (DOCM)
TipRanks · 08/20 10:16
DocMorris (DOCM) Receives a Hold from Berenberg Bank
TipRanks · 08/20 08:15
DocMorris: Buy Rating Reaffirmed as Fundamentals Improve, Price Target Unchanged at CHF9.50
TipRanks · 08/19 06:25
DocMorris Lifts 2026 Outlook on Surging Rx and Digital Services
TipRanks · 08/19 05:33
Barclays Reaffirms Their Hold Rating on DocMorris (DOCM)
TipRanks · 07/22 03:25
DocMorris upgraded to Neutral from Sell at UBS
TipRanks · 07/20 08:45
Barclays Remains a Hold on DocMorris (DOCM)
TipRanks · 07/16 06:06
UBS Remains a Sell on DocMorris (DOCM)
TipRanks · 07/15 10:05
DocMorris: Strong Rx Momentum and AI Strategy Support Buy Rating as CHF 9.50 Price Target Remains Unchanged
TipRanks · 07/15 06:45
DocMorris accelerates Rx and digital growth, tracks toward 2026 EBITDA breakeven
TipRanks · 07/15 05:32
Deutsche Bank upgrades DocMorris (DOCM) to a Buy
TipRanks · 07/13 09:25
More
Webull provides a variety of real-time ZRSEF stock news. You can receive the latest news about DocMorris through multiple platforms. This information may help you make smarter investment decisions.
About ZRSEF
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others